Design Therapeutics DSGN
NASDAQ DSGN
$12.62 +0.26 (+2.10%)
At close: Sep 29, 2026 · 4:00 PM EDT

Design Therapeutics (DSGN) FCF Margin (2020)

Updated

Design Therapeutics' FCF Margin came in at -8660.61% for Q4 2020, up 634.39 percentage points from the prior quarter.

Analysis

Design Therapeutics (DSGN) FCF Margin (2020) Analysis & Trends

For FY2020, Design Therapeutics' FCF Margin was -3869.47%.

  • The five-year range for quarterly FCF Margin is -9295.00% (Q3 2020) to -1872.54% (Q1 2020).
  • Business Quant data shows DSGN's FCF Margin at -9295.00% (Q3 2020), -4216.13% (Q2 2020) and -1872.54% (Q1 2020) in the three quarters before Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Design Therapeutics 773.49 Mn -82.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -8,660.61%
Sep 30, 2020 -9,295.00%
Jun 30, 2020 -4,216.13%
Mar 31, 2020 -1,872.54%
API Access

Design Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=DSGN&period=max&api_key=YOUR_API_KEY